Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

DJ US Pharmaceuticals Ishares (IHE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fund basics

See More
  • Fund Family BlackRock
  • Assets Under Management 632,286,100
  • Shares Outstanding, K 4,050

Price Performance

See More
Period Period Low Period High Performance
1-Month
148.65 +4.81%
on 08/23/17
158.81 -1.90%
on 09/12/17
+6.55 (+4.39%)
since 08/22/17
3-Month
146.65 +6.24%
on 08/21/17
160.50 -2.93%
on 06/26/17
-3.96 (-2.48%)
since 06/22/17
52-Week
129.20 +20.59%
on 11/04/16
160.92 -3.18%
on 06/22/17
-0.10 (-0.06%)
since 09/22/16

Most Recent Stories

More News
Q2 Earnings Fail to Impress Pharma ETF

The string of earnings beat failed to boost pharma ETFs.

XPH : 42.37 (+0.02%)
JNJ : 131.39 (-0.27%)
MRK : 65.13 (-0.72%)
IHE : 155.80 (-0.22%)
PJP : 64.81 (-0.22%)
LLY : 83.91 (+0.70%)
PFE : 35.96 (-0.03%)
BMY : 63.36 (+0.05%)
Q2 Earnings Fail to Impress Pharma ETF

The string of earnings beat failed to boost pharma ETFs.

XPH : 42.37 (+0.02%)
JNJ : 131.39 (-0.27%)
MRK : 65.13 (-0.72%)
IHE : 155.80 (-0.22%)
PJP : 64.81 (-0.22%)
LLY : 83.91 (+0.70%)
PFE : 35.96 (-0.03%)
BMY : 63.36 (+0.05%)
J&J Brightens Outlook: Healthcare ETFs in Focus

Johnson & Johnson continued its long streak of earnings beat and offered an upbeat outlook for the full year. However, it lagged our revenue estimate.

XLV : 81.58 (unch)
VHT : 152.21 (+0.01%)
JNJ : 131.39 (-0.27%)
IHE : 155.80 (-0.22%)
IYH : 171.97 (+0.05%)
FHLC : 39.39 (+0.08%)
J&J Brightens Outlook: Healthcare ETFs in Focus

Johnson & Johnson continued its long streak of earnings beat and offered an upbeat outlook for the full year. However, it lagged our revenue estimate.

XLV : 81.58 (unch)
VHT : 152.21 (+0.01%)
JNJ : 131.39 (-0.27%)
IHE : 155.80 (-0.22%)
IYH : 171.97 (+0.05%)
FHLC : 39.39 (+0.08%)
What Lies Ahead for Pharma ETFs in Second Half 2017

We discuss some of the factors that could contribute to a sustained recovery in the sector.

XPH : 42.37 (+0.02%)
PJP : 64.81 (-0.22%)
IHE : 155.80 (-0.22%)
PPH : 57.73 (+0.42%)
What Lies Ahead for Pharma ETFs in Second Half 2017

We discuss some of the factors that could contribute to a sustained recovery in the sector.

XPH : 42.37 (+0.02%)
PJP : 64.81 (-0.22%)
IHE : 155.80 (-0.22%)
PPH : 57.73 (+0.42%)
The Latest Market Trends Every Biopharma Investor Needs to Know

Speaking at MedCity INVEST, a national healthcare investing conference in Chicago hosted by MedCity News, Jonathan Norris of Silicon Valley Bank, alongside Ryan Jalowiecki from PwC, highlighted the latest...

IHE : 155.80 (-0.22%)
IBB : 329.94 (-0.40%)
XBI : 83.91 (-0.80%)
Lackluster J&J Q1 Pushes Healthcare ETFs Down

Johnson & Johnson continued its long streak of earnings beat but lagged our revenue estimate again on sluggish drug sales.

XLV : 81.58 (unch)
VHT : 152.21 (+0.01%)
JNJ : 131.39 (-0.27%)
IHE : 155.80 (-0.22%)
IYH : 171.97 (+0.05%)
FHLC : 39.39 (+0.08%)
PFE : 35.96 (-0.03%)
Lackluster J&J Q1 Pushes Healthcare ETFs Down

Johnson & Johnson continued its long streak of earnings beat but lagged our revenue estimate again on sluggish drug sales.

XLV : 81.58 (unch)
VHT : 152.21 (+0.01%)
JNJ : 131.39 (-0.27%)
IHE : 155.80 (-0.22%)
IYH : 171.97 (+0.05%)
FHLC : 39.39 (+0.08%)
PFE : 35.96 (-0.03%)
Trumpcare Collapse Fuels Rally in Healthcare Stocks & ETFs

With the failure of Trumpcare, the healthcare sector looks more stable.

UHS : 109.29 (+0.79%)
BBC : 28.20 (-1.74%)
AC : 34.85 (+1.01%)
XLV : 81.58 (unch)
IHE : 155.80 (-0.22%)
MOH : 65.32 (+4.50%)
LPNT : 57.20 (+1.96%)
THC : 16.32 (+2.51%)
BBP : 40.53 (-0.59%)
XPH : 42.37 (+0.02%)
PBE : 49.10 (-0.65%)
SBIO : 30.74 (-1.54%)
PJP : 64.81 (-0.22%)
CNC : 92.22 (+1.63%)
SPY : 249.44 (+0.02%)
XBI : 83.91 (-0.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Fund Summary

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The Fund seeks investment results that correspond to the price and yield of the Dow Jones U.S. Select Pharmaceuticals Index.

See More

Top 10 Holdings

Support & Resistance

2nd Resistance Point 156.23
1st Resistance Point 156.02
Last Price 155.80
1st Support Level 155.40
2nd Support Level 155.00

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.